PMI Spain CEO: Collaborating with New Health Minister for Public Health

Regulations by 2FIRSTS.ai
Jan.10.2024
PMI Spain CEO: Collaborating with New Health Minister for Public Health
PMI Spain CEO expresses desire to work with new Health Minister to strengthen tobacco prevention and protect non-smokers.

According to a report by Spain's European News Agency on January 9th, Daniel Cuevas, the President of PMI Spain, expressed his desire to further collaborate with the newly appointed Health Minister, Mónica García, in order to strengthen tobacco prevention measures and protect non-smokers and minors from the dangers of secondhand smoke.

 

Kwevas emphasized his support for strengthening the regulation of new tobacco products and acknowledged that progress in sales rules and taxes has not reached the expected pace. He specifically focused on regulation of packaging, flavors, and sales channels to ensure that these products do not end up in the hands of minors.

 

Although Cuevas believes that e-cigarettes are a substitute for traditional tobacco, he advocates for their inclusion in regulatory measures. He emphasizes that there should not be product packaging or flavors that may attract underage individuals, such as cartoon designs or flavors resembling candy or cheesecake. Cuevas expresses appreciation for the preliminary stance of the Minister of Health, noting that her primary objective is to protect public health, including the well-being of both smokers and non-smokers.

 

Quivas refers to this approach as the "progressive method," emphasizing the shared goal of protecting non-smokers and preventing children from smoking. He states that the company is willing to engage in dialogue with the Ministry of Health to jointly establish a solution for preventing smoking. In this regard, the company has formally requested a meeting with the Minister.

 

In addition, Kwiatkowski mentioned that he will be studying the air quality in public places such as restaurant patios in order to make informed decisions regarding tobacco and new nicotine consumption products. He expressed his respect for the research findings of independent research organizations and pledged to maintain an open attitude towards the impact on air quality.

 

Quivas believes that e-cigarettes and heated tobacco do not emit secondhand smoke and pose no harm to non-smokers. If research confirms this conclusion, he advocates for coexistence between smokers and non-smokers to prevent stigmatization of smokers. He acknowledges the Health Department's concerns regarding outdoor smoking and stresses the importance of being cautious when dealing with outdoor spaces.

 

Juarez is optimistic about the prospects of reconciliation with the public health sector and commends the company's efforts in transformation. He calls for the promotion and development of alternatives to prevent people from continuing to use traditional tobacco, thereby causing further harm.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
New Canadian research shows that 34.8% of people aged 17 to 27 have tried nicotine pouches, up more than fourfold from 7.6% in 2022. The findings come as Conservative politicians, Alberta’s government and the tobacco industry push Ottawa to relax current restrictions on pouch sales.
Jun.12
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20